AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03924830 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bulk with Biscover
Description: Adhese SE self-etch adhesive system will be applied according to the manufacturer's instructions in 53 teeth.Then, the Tetric N-Ceram Bulk fill composite will be used in increments of no more than 4 mm, using the bulk restoration technique, and each increment will be photoactivated for 40 seconds. After the restoration is completed, biscover surface sealant will be applied according to the manufacturer's instructions.
Study NCT03924830 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bulk with Permaseal
Description: Adhese SE self-etch adhesive system will be applied according to the manufacturer's instructions in 53 teeth.Then, the Tetric N-Ceram Bulk fill composite will be used in increments of no more than 4 mm, using the bulk restoration technique, and each increment will be photoactivated for 40 seconds. After the restoration is completed, Permaseal surface sealant will be applied according to the manufacturer's instructions.
Study NCT02382380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoterate
Description: Patients who choose to receive Gadoterate will receive an MRI exam with standard pre-contrast and Gadoterate-enhanced acquisitions (0.2 mL/kg). The MRI protocol utilized in the study will be comprised of the standard Body protocols (routine abdomen, liver-pancreas, renal, prostate, angiography) as well as the standard Neurologic exam protocols (routine brain, orbital, brainstem, neck, angiography).
Study NCT02382380 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Gadoterate
Description: Patients who choose not to receive Gadoterate will receive an MRI exam with no Gadolinium contrast. The MRI protocol utilized in the study will be comprised of the standard Body protocols (routine abdomen, liver-pancreas, renal, prostate, angiography) as well as the standard Neurologic exam protocols (routine brain, orbital, brainstem, neck, angiography).
Study NCT01280708 — intervention group
Intervention type: OTHER
Intervention: Capture data
Description: Capture and standardization of data of patients aged over 18 years received a kidney transplant or a simultaneous pancreas-kidney transplant from data sources will be performed by clinical research associates.The quality of data will be validated by cross annual audits. The statistical analysis will be made on a case by case according to clinical objectives.
Study NCT03353506 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: LFMT
Description: Lyophilized fecal microbiota transplant
Study NCT03353506 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LSFF
Description: Lyophilized sterile fecal filtrate
Study NCT04743986 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Description: RegenLab, Lausanne, Switzerland
Study NCT04743986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid (CS)
Description: 40mg/ml triamcinolone in 2 ml 0.5% bupivicaine
Study NCT00930072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cervical Sympathetic Block (bupivicaine, clonidine)
Description: 12-15ml solution of bupivicaine .5% containing 50 mcg of clonidine for cervical sympathetic block administered in a single injection.
Study NCT04140513 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Fludeoxyglucose F-18
Description: Given via injection
Study NCT04140513 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo dPET
Study NCT02640196 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Macintosh
Description: The participants intubated the easy airway simulator with a double lumen tube using the Macintosh laryngoscope followed with intubating the difficult airway simulator
Study NCT02640196 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: GlideScope
Description: The participants intubated the easy airway simulator with a double lumen tube using the GlideScope followed with intubating the difficult airway simulator
Study NCT02640196 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Airtraq
Description: The participants intubated the easy airway simulator with a double lumen tube using the Airtraq followed with intubating the difficult airway simulator
Study NCT02640196 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision
Description: The participants intubated the easy airway simulator with a double lumen tube using the King Vision followed with intubating the difficult airway simulator
Study NCT04464018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: working grup
Description: After each student received theoretical training, they performed an intravenous injection on the model. In the study group performed hybrid simulation. After finishing the simulation application. the students went to the analysis room and watched their own application videos. The analysis session was held immediately after all the students in the group completed their applications.The IM injection success Test and Student Satisfaction and self-confidence scale were applied to the study and control groups after the laboratory application was completed.
Study NCT00925925 — intervention group
Intervention type: OTHER
Intervention: Cord blood collection for analysis
Description: Cord blood will be collected from the placentas at delivery for analysis
Study NCT03290924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low dose high frequency health worker training approach
Description: * Two 4-day training sessions for skilled birth attendants~* 1-day peer practice coordinator training after first training session~* Weekly, peer-led practice sessions using MamaNatalie® and NeoNatalie™ anatomic models~* SMS reminder messages and quizzes~* Routine telephone calls between master mentors and peer practice coordinators, and between project staff and master mentors~* Health information officer training~* Data collection and use training~* Supply of simulators, newborn resuscitation equipment, and delivery sets
Study NCT03290924 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparison
Description: Training on data collection and reporting
Study NCT00314795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginesatide
Description: Peginesatide injection
Study NCT03783715 — intervention group
Intervention type: DRUG
Intervention: Ketoprofen
Description: Ketoprofen 200 mg ER, taken orally, once a day for 6 months. If medication, if obtained from a compound pharmacy, dose will be 210 mg ER, taken orally once a day for 6 months.
Study NCT04335734 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nissen Fundoplication with wrap fixation
Description: Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures. Wrap was fixated to both diaphragmatic crura or to the body of stomach using two non-absorbable stitches on each side.
Study NCT04335734 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nissen Fundoplication without wrap fixation
Description: Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures.
Study NCT01493167 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: limb casting/splinting
Description: ankle and arm cast
Study NCT03351283 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Severe sodium restriction
Description: Patients will be assigned to a diet with sodium restriction of two grams.
Study NCT03351283 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate sodium restriction
Description: Patients will be assigned to a diet with sodium restriction of three grams.
Study NCT01010867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum strains 299 and 299v
Description: Patients will receive a daily dose of Lactobacillus plantarum: 1 x10\^8 CFU/kg/day. This supplement will be supplied in sachets of powder and will be mixed in water (certain water-based liquid) that is no warmer that 37o C.~Colony forming units (CFU)
Study NCT04172818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: quality of life questionnaire
Description: Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma.In analogy, the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences. The psychological impact of a diary on patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives will be evaluated.
Study NCT02039843 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Support Dogs
Description: Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.
Study NCT02039843 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Service Dogs
Description: Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
Study NCT00884741 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo 3-dimentional conformal radiation therapy
Study NCT00884741 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo 3-dimentional conformal radiation therapy
Study NCT00884741 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT00884741 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo intensity-modulated radiation therapy
Study NCT00884741 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo intensity-modulated radiation therapy
Study NCT00884741 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00884741 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00884741 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Given IV
Study NCT00884741 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT00884741 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT00884741 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temozolomide
Description: Given orally
Study NCT00884741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given orally
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozadenant
Description: 2, 4, 6 or 8 Tozadenant 60 mg tablets
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: 2, 4, 6 or 8 Tozadenant matching placebo tablets
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral tablet
Description: 2, 4, 6 or 8 Tozadenant matching placebo tablets
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: d-amphetamine
Description: 2 or 4 capsules, each containing 2 over-encapsulated d-amphetamine 5 mg tablets
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet
Study NCT03200080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet
Study NCT04521725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Function Monitor (RFM)
Description: Use of respiratory function monitor to detect tidal volume and expired CO2 to guide mask ventilation during neonatal resuscitation.
Study NCT04521725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral Near-Infrared Spectroscopy (NIRS)
Description: Use of cerebral NIRS to determine cerebral oxygenation to guide oxygen titration during neonatal resuscitation.
Study NCT01017913 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: TENS
Description: The TENS equipment was calibrated on 20 hertz frequency, and a pulse width of 330 ms (standing in control number seven) with two channels.
Study NCT01017913 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS
Description: The TENS equipment was calibrated on 20 hertz frequency, and a pulse width of 330 ms (standing in control number seven) with two channels.
Study NCT01017913 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interferential currents
Description: The IFC was adjusted to a base frequency of 4000 Hz, with a modulation frequency range of 20 Hz, ∆F of 10 Hz and slope of 1/1, in quadripolar mode.
Study NCT02717806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PATHway
Description: Patients will use the PATHway platform for 6 months
Study NCT01214733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tocilizumab [RoActemra/Actemra]
Description: 8 mg/kg intravenously every 4 weeks in combination with allowed DMARDs
Study NCT04174326 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate intervention group
Description: Participants will be randomized to either the immediate or delayed intervention group at baseline. Participants in both groups will receive CBT for chronic pain management sequentially, once a week during the 6 week intervention period. Participants will be followed-up at 18 weeks from baseline. Two in-between sessions practice assignments will be added to each group therapy session during the the CBT program.
Study NCT02049593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PARP inhibitor BMN-673
Description: Given PO
Study NCT02049593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide
Description: Given PO
Study NCT02049593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irinotecan hydrochloride
Description: Given IV
Study NCT02049593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT02049593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT02055118 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: idursulfase-IT
Description: 10mg
Study NCT02055118 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No IT treatment
Description: Standard of Care
Study NCT00646269 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard intervention protocol
Description: The control group involves a standardized medical follow-up of patients with Alzheimer's disease and a psychoeducative group program for caregivers of patients.
Study NCT00646269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard intervention protocol + Cognitive training therapy
Description: Cognitive training therapy is provided in small groups of 5 to 8 patients. It consists in classroom type sessions designed to provide general cognitive stimulation. A set of standard cognitive exercises (involving memory, attention, or problem-solving...) related to activities of daily living is realized at each session.
Study NCT00646269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard intervention protocol + Reminiscence therapy
Description: Reminiscence therapy is provided in small groups of 5 to 8 patients. This therapy involves the discussion of past activities, events and experiences enhanced by aids such as photographs, familiar items, songs, or personal recordings. A particular topic of life (i.e. a wedding) is discussed at each session.
Study NCT00646269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard intervention protocol + Made-to-measure program
Description: The made to measure program involves no systematic intervention. The psychologist is asked to choose among the two possible therapies (Cognitive training therapy or Reminiscence therapy) the one more suitable for the patient after considering his clinical characteristics including socio-demographic characteristics, disease severity or cognitive and behavioural disturbance. It is an individualized approach emphasizing the importance of flexibility to allow adjustment to individual needs.
Study NCT00726011 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetrodotoxin
Description: 30 µg twice daily for 4 days; repeated every two weeks as long as there is a meaningful analgesic response
Study NCT03944252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: avelumab 10 mg/kg iv day 1; To be repeated every 2 weeks (14 days) until progression of disease, refuse or inacceptable toxicity.
Study NCT03944252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: cetuximab 500 mg/m2 plus avelumab 10 mg/kg iv day 1. To be repeated every 2 weeks (14 days) until progression of disease, refuse or inacceptable toxicity.
Study NCT02561338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Description: 75mgQD
Study NCT02561338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Description: 100mgQD
Study NCT02561338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Description: 50mgBID
Study NCT02561338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Description: 75mgBID
Study NCT02561338 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: QD/BID
Study NCT01785485 — intervention group
Intervention type: OTHER
Intervention: Integrative medicine primary care model
Description: An integrative medicine primary medical care as defined by the Arizona Center for Integrative Medicine.
Study NCT01147913 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized Information-Processing Bias Retraining
Description: The intervention consists of the presentation of three-line ambiguous scenarios via a computer program, one line at a time. A disambiguating word fragment completes the scenario (in either a positive or neutral valence, depending on the scenario), after which participants will type the first letter of the word on the keyboard to ensure they are encoding the interpretation valence. The computer will indicate if they have correctly identified the word. This is followed by a Y/N comprehension question. Each session presents 100 training scenarios.
Study NCT01147913 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Attention Control Training
Description: Four sessions of interpretation training for filler or neutral scenarios, unrelated to themes associated with depression.
Study NCT04541459 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: new device against ambient electromagnetic radiation
Description: New device provides protection against the radiations emitted by the smartphone and laptop devices. Device uses conductive fluids in a particular geometric arrangement intended to ameliorate the negative effects of EMW radiation.
Study NCT04541459 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham device against ambient electromagnetic radiation
Description: Sham device as as a control for new device, which provides protection against the radiations emitted by the smartphone and laptop devices. Device uses conductive fluids in a particular geometric arrangement intended to ameliorate the negative effects of EMW radiation.
Study NCT03766152 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Adhesive bone conduction hearing aid (ADHEAR - Med El)
Description: Patients are asked to wear an adhesive bone conduction hearing device which is attached to the mastoid with an adhesive adapter
Study NCT01033448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: COPEGUS
Description: COPEGUS 800 mg or 1000-1200 mg po for 24 weeks
Study NCT01033448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a [Pegasys]
Description: PEGASYS 180 micrograms sc once weekly for 24 weeks
Study NCT01744080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regular Wait Time
Description: Surgery will take place no earlier than 9 months and no later than 12 months after the sport medicine physician consult.
Study NCT01744080 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Early Surgery
Description: Patient will proceed to have rotator cuff repair surgery within 3 months of the initial consult with the sport medicine physician.
Study NCT01170572 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention